Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

被引：0

作者：

Cabibbo, G. ^{[1
]}

Cacciola, I. ^{[2
]}

Cannavo, M. R. ^{[3
]}

Madonia, S. ^{[4
]}

Calvaruso, V. ^{[5
]}

Petta, S. ^{[1
]}

Di Stefano, M. ^{[6
]}

Larocca, L. ^{[7
]}

Prestileo, T. ^{[8
]}

Tine, F. ^{[9
]}

Digiacomo, A. ^{[10
]}

Bertino, G. ^{[11
]}

Giannitrapani, L. ^{[12
]}

Benanti, F. ^{[13
]}

Davi, A. ^{[14
]}

Volpes, R. ^{[15
]}

Guarneri, L. ^{[16
]}

Averna, A. ^{[17
]}

Scalisi, I. ^{[18
]}

Iacobello, C. ^{[19
]}

Mazzola, G. ^{[20
]}

Cartabellotta, F. ^{[21
]}

Portelli, V. ^{[22
]}

Russello, M. ^{[23
]}

Scifo, G. ^{[24
]}

Squadrito, G. ^{[25
]}

Raimondo, G. ^{[25
]}

Craxi, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

机构：

[1] Univ Palermo, Gastroenterol & Epatol, DIBIMIS, Palermo, Italy

[2] AOUP G Di Martino, Epatol Clin & Mol, Messina, Italy

[3] ARNAS Garibaldi Nesima, UOD Epatol, Catania, Italy

[4] AO Cervello Villa Sofia, Med Interna, Palermo, Italy

[5] Univ Palermo, Gastroenterol & Epatol, Palermo, Italy

[6] UmbertoIO, Malattie Infett, Siracusa, Italy

[7] AOUP Vittorio Emanuele, Malattie INfett, Catania, Italy

[8] ARNAS Civ Di Cristina Benefratelli, Malattie Infett, Palermo, Italy

[9] AO Cervello Villa Sofia, Gastroenterol, Palermo, Italy

[10] Presidio Osped, Med Interna, Comiso, Italy

[11] Vittorio Emanuele, Med Interna & Urgenza, Catania, Italy

[12] Univ Palermo, Med Interna, Palermo, Italy

[13] Garibaldi Nesima, Malattie Infett, Catania, Italy

[14] Presidio Osped Modica, Malattie Infett, Modica, Italy

[15] ISMETT, Palermo, Italy

[16] Umberto I, Malattie Infett, Enna, Italy

[17] S Elia, Malattie Infett, Caltanissetta, Italy

[18] Presidio Osped Castelvetrano, Med Interna, Trapani, Italy

[19] Cannizzaro, Malattie Infett, Catania, Italy

[20] Univ Palermo, Malattie Infett, Palermo, Italy

[21] Buccheri La Ferla, Med Interna, Palermo, Israel

[22] PO, Malattie Infett, Trapani, Israel

[23] Garibaldi, Gastroenterol, Catania, Italy

[24] Umberto I, Malattie Infett, Siracusa, Italy

[25] Univ Messina, Epatol Clin & Mol, Messina, Italy

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30734-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-096

引用

页码：S218 / S218

页数：1

共 50 条

[41] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
Aggeletopoulou, Ioanna
Konstantakis, Christos
Manolakopoulos, Spilios
Triantos, Christos
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (24) : 4317 - 4323
[42] Risk of hepatocellular carcinoma in patients with chronic hepatitis C treated with directacting antivirals
Yoo, Sun Hong
Nam, Soon Woo
Kwon, Jung Hyun
Kim, Hee Yeon
Kim, Chang Wook
You, Chan Ran
Choi, Sang Wook
Song, Do Seon
Chang, U. Im
Yang, Jinmo
Lee, Sung Won
Lee, Hae Lim
Song, Myeong Jun
Sung, Pil Soo
Jang, Jeong Won
Bae, Si Hyun
Hwang, Seawon
Kim, Seok Hwan
HEPATOLOGY, 2017, 66 : 560A - 561A
[43] Decreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitis C: a meta-analysis
Lui, Felix H.
Moosvi, Zain
Patel, Anish
Hussain, Samiya
Duong, Alex
Duong, Jacqueline
Nguyen, Douglas L.
ANNALS OF GASTROENTEROLOGY, 2020, 33 (03): : 293 - 298
[44] Risk of hepatocellular carcinoma recurrence in patients treated with direct acting antiviral therapy
Kilsny, Shimaa
Gomaa, Asmaa
Sabry, Aliaa
Moaz, Inas
Ezzat, Sameera
Elwaraky, Mohamed
Badra, Gamal
Waked, Imam
JOURNAL OF HEPATOLOGY, 2020, 73 : S606 - S606
[45] Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
Virlogeux, Victor
Pradat, Pierre
Hartig-Lavie, Kerstin
Bailly, Francois
Maynard, Marianne
Ouziel, Guillaume
Poinsot, Domitille
Lebosse, Fanny
Ecochard, Marie
Radenne, Sylvie
Benmakhlouf, Samir
Koffi, Joseph
Lack, Philippe
Scholtes, Caroline
Uhres, Anne-Claire
Ducerf, Christian
Mabrut, Jean-Yves
Rode, Agnes
Levrero, Massimo
Combet, Christophe
Merle, Philippe
Zoulim, Fabien
LIVER INTERNATIONAL, 2017, 37 (08) : 1122 - 1127
[46] Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals
Calvaruso, V.
Cabibbo, G.
Cacciola, I.
Petta, S.
Madonia, S.
Bellia, A.
Stefano, M. D.
Giannitrapani, L.
Tine, F.
Magro, A.
Davi, A.
Larocca, L.
Ardiri, A.
Digiacomo, A.
Gussio, M.
Guarneri, L.
Scalisi, I.
Mazzola, G.
Cartabellotta, F.
Savalli, F.
Russello, M.
Scifo, G.
Squadrito, G.
Camma, C.
Raimondo, G.
Craxi, A.
Di Marco, V.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S23 - S24
[47] Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients
Degasperi, E.
Galmozzi, E.
Facchetti, F.
D'Ambrosio, R.
Soffredini, R.
Borghi, M.
Perbellini, R.
Iavarone, M.
Sangiovanni, A.
Lampertico, P.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E67 - E67
[48] A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C
Gorgen, A.
Galvin, Z.
Huang, A.
Zhang, W.
Vinaixa, C.
Berenguer, M.
Rubin, A.
Calatayud, D.
Mehta, N.
Terrault, N.
Selzner, N.
Sapisochin, G.
TRANSPLANTATION, 2018, 102 : 183 - 183
[49] Advances in the Era of Direct-Acting Antivirals for Hepatitis C in Patients with Unresectable Hepatocellular Carcinoma
Chen, Li-Shu
Lee, Shou-Wu
Yang, Sheng-Shun
Tsai, Hsin-Ju
Lee, Teng-Yu
DIGESTIVE DISEASES, 2022, 40 (05) : 616 - 624
[50] Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
Lee, Chang Hun
Kim, In Hee
GUT AND LIVER, 2021, 15 (03) : 327 - 328

← 1 2 3 4 5 →